M
Monique Nijhuis
Researcher at Utrecht University
Publications - 126
Citations - 7554
Monique Nijhuis is an academic researcher from Utrecht University. The author has contributed to research in topics: Virus & Viral load. The author has an hindex of 39, co-authored 109 publications receiving 6764 citations.
Papers
More filters
Journal ArticleDOI
Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC)
Rob Schuurman,Monique Nijhuis,Remko van Leeuwen,Pauline J. Schipper,Dorien de Jong,Phil Collis,Sven A. Danner,John Mulder,Clive Loveday,Cindy Christopherson,Shirley Kwok,John J. Sninsky,Charles A. Boucher +12 more
TL;DR: It is shown that the rapid appearance of drug-resistant virus in serum is followed by an increase in viral RNA load, which is similar to that seen in patients treated with the reverse transcriptase inhibitor lamivudine.
Journal ArticleDOI
Simultaneous Detection of Influenza Viruses A and B Using Real-Time Quantitative PCR
TL;DR: This method simultaneously detects influenza viruses A and B in specimens of patients with respiratory infections using a TaqMan-based real-time PCR assay, which was found to be more sensitive than the combination of conventional viral culturing and shell vial culturing.
Journal ArticleDOI
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.
Monique Nijhuis,Rob Schuurman,Dorien de Jong,John W. Erickson,Elena Gustchina,Jan Albert,Pauline J. Schipper,Sergei V. Gulnik,Charles A. Boucher +8 more
TL;DR: The evolution and fitness of viral populations appearing in a patient who received protease monotherapy indicates that the viral population in the patient does not have to represent the fittest possible variants, and thus antiretroviral therapy may drive the viral populations first through a lower fitness level and then to a higher fitness level.
Journal ArticleDOI
International AIDS Society global scientific strategy: towards an HIV cure 2016
Steven G. Deeks,Sharon R Lewin,Anna Laura Ross,Jintanat Ananworanich,Monsef Benkirane,Paula M. Cannon,Nicolas Chomont,Daniel C. Douek,Jeffrey D. Lifson,Ying-Ru Lo,Daniel R. Kuritzkes,David M. Margolis,John W. Mellors,Deborah Persaud,Joseph D. Tucker,Françoise Barré-Sinoussi,Galit Alter,Judith D. Auerbach,Brigitte Autran,Dan H. Barouch,Georg M. N. Behrens,Marina Cavazzana,Zhiwei Chen,Éric A. Cohen,Giulio Maria Corbelli,Serge Eholié,Nir Eyal,Sarah Fidler,Laurindo Garcia,Cynthia I. Grossman,Gail E. Henderson,Timothy J. Henrich,Richard Jefferys,Hans-Peter Kiem,Joseph M. McCune,Keymanthri Moodley,Peter A. Newman,Monique Nijhuis,Moses Supercharger Nsubuga,Melanie Ott,Sarah Palmer,Douglas D. Richman,Asier Sáez-Cirión,Matthew G.F. Sharp,Janet M. Siliciano,Guido Silvestri,Jerome Amir Singh,Bruno Spire,Jeff Taylor,Martin Tolstrup,Susana T. Valente,Jan van Lunzen,Rochelle P. Walensky,Ira B. Wilson,Jerome A. Zack +54 more
TL;DR: A group of international experts to develop a scientific strategy for research towards an HIV cure summarized the group's strategy in this Perspective.
Journal ArticleDOI
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation
Ravindra K. Gupta,Sultan Abdul-Jawad,Laura E. McCoy,Hoi Ping Mok,Dimitra Peppa,Maria Salgado,Javier Martinez-Picado,Javier Martinez-Picado,Monique Nijhuis,Annemarie M. J. Wensing,Helen Lee,Paul Grant,Eleni Nastouli,Jonathan Lambert,M Pace,Fanny Salasc,Christopher Monit,Andrew J. Innes,Andrew J. Innes,Luke Muir,Laura Waters,John Frater,Andrew M. L. Lever,Andrew M. L. Lever,Simon Edwards,Ian H Gabriel,Ian H Gabriel,Eduardo Olavarria,Eduardo Olavarria +28 more
TL;DR: It is suggested that a single allogeneic HSCT with homozygous CCR5Δ32 donor cells may be sufficient to achieve HIV-1 remission with reduced intensity conditioning and no irradiation, and the findings provide further support for the development of HIV- 1 remission strategies based on preventing CCR 5 expression.